Buy Rating for Apellis Pharmaceuticals: Strong Empaveli Launch and Long-term Syfovre Potential
at www.tipranks.com (Thu, 4-Dec 4:55 AM)
Citi Reaffirms Their Buy Rating on Apellis Pharmaceuticals (APLS)
at www.tipranks.com (Wed, 3-Dec 7:47 PM)
